NCT03208894View on ClinicalTrials.gov

Role of Salbutamol and Furosemide in TTN

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

June 30, 2017

Conditions
Transient Tachypnea of the Newborn
Interventions
DRUG

Furosemide Injection

efficacy of salbutamol and furosemide in TTN

Trial Locations (2)

68000

Department of Pediatrics, Rawalpindi

Military Hospital, Rawalpindi

All Listed Sponsors
lead

Armed Forces Hospital, Pakistan

OTHER

NCT03208894 - Role of Salbutamol and Furosemide in TTN | Biotech Hunter | Biotech Hunter